Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer [Phase 2]
Phase 2 clinical trial investigating whether high-dose Vitamin C can improve quality of life in patients with metastatic pancreatic cancer; …
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating nintedanib in combination with chemotherapy for advanced pancreatic cancer was terminated, with results posted …
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: The Effect of Probiotics ATG-F4 in Cancer Patients [Phase 2]
A Phase 2 trial is evaluating the probiotic ATG-F4 in patients with pancreatic cancer and colorectal cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: U87 CART in Treatment of Advanced Solid Tumor [Phase 1]
Phase 1 clinical trial update for U87 CART therapy in adults with advanced solid tumors, including pancreatic cancer; trial status is UNKNOW…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Quality of Life in Elderly Patients After Pancreatic Cancer Surgery
A completed clinical trial update reporting outcomes on quality of life in elderly patients following pancreatic cancer surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer [Phase 1]
This Phase 1 study evaluates the efficacy and safety of CT041 in pancreatic cancer patients after adjuvant chemotherapy.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating nimotuzumab plus NALIRIFOX for locally advanced pancreatic cancer is listed as ACTIVE_NOT_RECRUITING; sponsor is Pe…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. [Phase 2]
A Phase 2 trial evaluating immunotherapy combined with radiation and an influenza vaccine for pancreatic cancer was terminated.
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Pancreatic Cancer Early Detection Program
A clinical trial update for White Plains Hospital describes an active, not currently recruiting program focused on early detection of pancre…
-
FDA approval · 2024-05-24FDA Approved: ERLOTINIB — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for Erlotinib (ERLOTINIB), enabling a generic version of the cancer drug to be…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) [Phase 2]
The CBART trial (Central-boost Ablative Radiation Therapy) for pancreatic cancer is a Phase 2 study currently recruiting to evaluate this ra…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy [Phase 1, Phase 2]
Phase 1/2 pancreatic cancer vaccine QUILT-3.070 from ImmunityBio was terminated with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer [NA]
This clinical trial update notes termination of a study evaluating blue and amber light exposure in patients with pancreatic and rectal canc…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer [Phase 2]
A Phase 2b trial evaluating GC4711 in combination with SBRT for nonmetastatic pancreatic cancer was terminated, with results posted in May 2…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of SBRT, nimotuzumab, and mono-chemotherapy for locally advanced pancreatic cancer; t…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Prospective clinical trial evaluating whether peripheral blood cell-free DNA sequencing can screen for and differentiate among several commo…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer [Phase 2]
Clinical trial update on a Phase 2 study evaluating a modified FOLFIRINOX regimen alternated with biweekly gemcitabine plus nab-paclitaxel i…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors [NA]
This clinical trial update reports on the role of circulating tumor cells spread during pancreaticoduodenectomy in patients with pancreatic …
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
Adenocyte's LINFU U.S. Registry study for patients with pancreatic cancer presenting with signs or symptoms is not yet recruiting.
-
CLINICAL_TRIALS other · 2024-05-13Clinical Trial Update: Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
A clinical trial is currently recruiting to study gastrointestinal microflora and serum metabolomics in patients with pancreatic cancer and …
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study of nimotuzumab combined with GX as postoperative adjuvant therapy in pancreatic cancer, no…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. [Phase 2]
Phase 2 trial evaluating Penpulimab and Anlotinib with Nab-paclitaxel and Gemcitabine in metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating HR070803 in combination with oxaliplatin and 5-FU/leucovorin versus AG for first-line treatment of advanced pancrea…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study [Phase 2]
A phase II, single-arm trial is evaluating nimotuzumab in combination with the AG regimen (gemcitabine plus nab-paclitaxel) for pancreatic c…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy [NA]
A completed pilot clinical trial evaluates whether a high-protein supplement plus exercise therapy preserves skeletal muscle mass and improv…